Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 20 - Number 1



Review Article


Review Article

Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases

, 20(1): 19 - 32

Martyna Godzieba* and Slawomir Ciesielski


DOI: 10.2174/1568009619666191007112516



Review Article

Ellipticine, its Derivatives: Re-evaluation of Clinical Suitability with the Aid of Drug Delivery Systems

, 20(1): 33 - 46

Vipin Mohan Dan, Thania Sara Varghese, Gayathri Viswanathan and Sabulal Baby*


DOI: 10.2174/1568009619666190927150131



Research Article

Well-defined Graphene Oxide as a Potential Component in Lung Cancer Therapy

, 20(1): 47 - 58

Agnieszka Zuchowska, Elzbieta Jastrzebska, Marta Mazurkiewicz-Pawlicka, Artur Malolepszy, Leszek Stobinski, Maciej Trzaskowski and Zbigniew Brzozka*


DOI: 10.2174/1568009619666191021113807



Research Article

C/EBPα Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPARγ in Hepatocellular Carcinoma

, 20(1): 59 - 66

Zhuo Xu, Shao-Hua Meng, Jian-Guo Bai, Chao Sun*, Li-Li Zhao*, Rui-Feng Tang, Zhao-Lin Yin, Jun-Wei Ji, Wei Yang and Guang-Jun Ma


DOI: 10.2174/1568009619666190912161003



Research Article

ERGIC3 Silencing Additively Enhances the Growth Inhibition of BFA on Lung Adenocarcinoma Cells

, 20(1): 67 - 75

Qiurong Zhao, Mingsong Wu, Xiang Zheng, Lei Yang, Zhimin Zhang, Xueying Li* and Jindong Chen*


DOI: 10.2174/1568009619666190917145906



Research Article

Sam68 Promotes the Progression of Human Breast Cancer through inducing Activation of EphA3

, 20(1): 76 - 83

Xinxin Chen*, Lehong Zhang*, Min Yuan, Ziqiao Kuang, Ying Zou, Tian Tang, Wangjian Zhang, Xiaowu Hu, Ting Xia , Tengfei Cao and Haixia Jia


DOI: 10.2174/1568009619666190718124541




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

webinar-July-21July-2021-ban

Related Journals

Related eBooks

eBooks Catalog